Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INDIE-HFpEF
NCT02742129Phase 2Completed
- Start
- Aug 2016
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of inhaled nitrite in heart failure with preserved ejection fraction (HFpEF) (2 arms). Primary endpoint: Peak Oxygen Uptake. Started Aug 2016; status: completed.
02
Drugs
inhaled nitrite
03
Conditions
heart failure with preserved ejection fraction (HFpEF)
Beyond the preview
Go deeper on NCT02742129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02742129.